Telesis Bio Inc. Quarterly Operating Income (Loss) in USD from Q2 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Telesis Bio Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2024.
  • Telesis Bio Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$5.48M, a 41.6% increase year-over-year.
  • Telesis Bio Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$44.2M, a 24% decline year-over-year.
  • Telesis Bio Inc. annual Operating Income (Loss) for 2023 was -$46.5M, a 0.12% decline from 2022.
  • Telesis Bio Inc. annual Operating Income (Loss) for 2022 was -$46.5M, a 31.4% decline from 2021.
  • Telesis Bio Inc. annual Operating Income (Loss) for 2021 was -$35.4M, a 116% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$44.2M -$5.48M +$3.9M +41.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$48.1M -$11.5M -$4.05M -54.4% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$44.1M -$8.52M +$2.45M +22.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$46.5M -$18.7M -$10.9M -138% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$35.7M -$9.38M +$1.87M +16.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$37.5M -$7.44M +$7.05M +48.6% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$44.6M -$11M +$1.89M +14.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$46.5M -$7.88M +$4.21M +34.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 -$50.7M -$11.3M -$1.81M -19.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 -$48.9M -$14.5M -$6.92M -91.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 -$42M -$12.9M -$6.6M -105% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 -$35.4M -$12.1M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 -$9.44M -$5.14M -120% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$7.57M -$4.28M -130% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 -$6.26M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 -$4.3M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$3.3M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.